The Oil Change for Antibody-Mediated Neurological Diseases
This year at the International Symposium on Clinical Neuroscience, Dr. Justin Kreuter will be discussing the clinical applications of plasma exchange.
Dr. Kreuter is a Harvard Macy Alumnus and the associate program director for the Mayo Clinic transfusion medicine/blood banking fellowship. He has been involved with several quality improvement initiatives related to medical education, including one in Critical Care that was awarded the Afessa Award for Excellence in quality improvement and another project that was recognized with an Excellence Through Teamwork Award.
– Hello, my name is Dr. Freddys Garcia and we are joined today by Dr. Justin Kreuter, Dr. Kreuter how you doing today?
– Doing fantastic, thanks.
– I brought you on the show today because you are presenting at this year’s International Symposium on Clinical Neuroscience, the ISCN, which takes place on May 24th through 26th in Orlando, Florida. We are excited to have you there.
– I’m excited to be there, too, thanks.
– Now, you may be new to some of our scholars but you have an amazing background. Would you mind telling us a little bit about yourself?
– Yeah, I’m a clinical pathologist at Mayo Clinic in Rochester, Minnesota. I am a transfusion medicine physician and I also do transplant medicine, as well.
– Fascinating. Now your topic, I think, is very cool. Your topic is: plasma exchange, the oil change for anti-body mediated neurological diseases. Now, this is fascinating to me. Why did you choose this topic and why is it important for our scholars to learn more about it?
– Great question. Plasma exchange is a part of my practice as a pathologist, and it’s something that, although there are a lot of physicians that may order a plasma exchange, or request a plasma exchange, they may not be as familiar as into how it works, and also what the guidelines are. The association for apheresis, the American association for apheresis, has put together a clinical guideline. They literally review the world’s literature on a rolling three-year basis and put together guidelines, and something I wanted to do to help the audience understand is to understand where that guideline exists and how to read that so that they can make more appropriate decisions on how to care for their patients.
– Fantastic, I know autoimmune conditions is a topic of large interest to our audience, so I think this is going to be amazing. Dr. Kreuter, thank you so much for your time today. Again, you’re going to be presenting on May 24th through 26th in Orlando, Florida, at this year’s ISCN, we can’t wait to see you there.
– Awesome, I’ll see you there.